微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.41% | 45.18% | 82.58% | 78/157 | 1.37% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 1.32% | 37.5% | -64.03% | 76/157 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 3.67% | 60.26% | -13.85% | 74/157 | -4.46% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 4.26% | 43.92% | 156.63% | 69/157 | 1.31% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 1.66% | 78.49% | 72.92% | 85/157 | 0.3% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.96% | 43.28% | -58.08% | 82/157 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 2.29% | 458.54% | -22.64% | 83/157 | -9.62% | 百利天恒药业 | 181.27% | 行业排名> |
| 2024-09-30 | 2.96% | 14.29% | 218.28% | 87/157 | 4.28% | 百利天恒药业 | 186.1% | 行业排名> |
| 2024-06-30 | 0.93% | -24.39% | 38.81% | 104/157 | 2.69% | 百利天恒药业 | 186.89% | 行业排名> |
| 2024-03-31 | 0.67% | -67.48% | 63.41% | 102/157 | 2.35% | 百利天恒药业 | 188.56% | 行业排名> |
| 2023-12-31 | 0.41% | -96.6% | -84.17% | 99/157 | -1% | 上海小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.59% | -77.52% | 110.57% | 96/157 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.23% | -86.73% | -40.29% | 97/157 | 1.48% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 2.06% | -67.66% | -82.9% | 60/157 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 12.05% | 59.6% | 4.6% | 31/157 | 0.79% | 上海小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 11.52% | 47.31% | 24.27% | 22/157 | 2.86% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 9.27% | 62.06% | 45.53% | 13/157 | 2.21% | 上海小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 6.37% | 109.54% | -15.63% | 5/157 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.55% | 36.04% | -3.45% | 60/157 | 0.84% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 7.82% | -18.88% | 36.71% | 55/157 | 4.46% | 上海小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.72% | -14.5% | 88.16% | 43/157 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.04% | -3.49% | -45.23% | 40/157 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 5.55% | -49.73% | -42.43% | 80/157 | 3.8% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 9.64% | -5.86% | 44.1% | 38/157 | 3.13% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 6.69% | 5.69% | 112.38% | 37/157 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 3.15% | -9.22% | -71.47% | 32/157 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.04% | 87.12% | 7.81% | 52/157 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 10.24% | 80.92% | 61.77% | 34/157 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 6.33% | 279.04% | 82.42% | 34/157 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.47% | 395.71% | -41.19% | 28/157 | 2.45% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.9% | 75.07% | 4.24% | 76/157 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.66% | 59.44% | 238.92% | 59/157 | 7.21% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.67% | -45.07% | 138.57% | 86/157 | 4.63% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.7% | -47.37% | -79.23% | 84/157 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 3.37% | -70.07% | -5.07% | 97/157 | 9.62% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.55% | 2% | 16.78% | 69/157 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.04% | -58.13% | 128.57% | 70/157 | 5.56% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.33% | 2% | -88.19% | 57/157 | 2.1% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 11.26% | -4.33% | -4.33% | 46/157 | 6.05% | 华东医药 | 7.2% | 行业排名> |